- Home
- CXAI vs LGVN Comparison
CXAI vs LGVN Comparison
Compare CXAI & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- LGVN
- Stock Information
- Founded
- CXAI N/A
- LGVN 2014
- Country
- CXAI United States
- LGVN United States
- Employees
- CXAI N/A
- LGVN N/A
- Industry
- CXAI EDP Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- CXAI Technology
- LGVN Health Care
- Exchange
- CXAI Nasdaq
- LGVN Nasdaq
- Market Cap
- CXAI 16.0M
- LGVN 16.4M
- IPO Year
- CXAI N/A
- LGVN 2021
- Fundamental
- Price
- CXAI $0.72
- LGVN $0.75
- Analyst Decision
- CXAI
- LGVN Strong Buy
- Analyst Count
- CXAI 0
- LGVN 2
- Target Price
- CXAI N/A
- LGVN $6.50
- AVG Volume (30 Days)
- CXAI 630.4K
- LGVN 416.4K
- Earning Date
- CXAI 11-11-2025
- LGVN 11-11-2025
- Dividend Yield
- CXAI N/A
- LGVN N/A
- EPS Growth
- CXAI N/A
- LGVN N/A
- EPS
- CXAI N/A
- LGVN N/A
- Revenue
- CXAI $6,005,000.00
- LGVN $2,073,000.00
- Revenue This Year
- CXAI N/A
- LGVN N/A
- Revenue Next Year
- CXAI $60.00
- LGVN N/A
- P/E Ratio
- CXAI N/A
- LGVN N/A
- Revenue Growth
- CXAI N/A
- LGVN 68.67
- 52 Week Low
- CXAI $0.61
- LGVN $0.63
- 52 Week High
- CXAI $2.54
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- CXAI 41.98
- LGVN 35.53
- Support Level
- CXAI $0.70
- LGVN $0.74
- Resistance Level
- CXAI $0.79
- LGVN $0.85
- Average True Range (ATR)
- CXAI 0.05
- LGVN 0.05
- MACD
- CXAI 0.01
- LGVN 0.02
- Stochastic Oscillator
- CXAI 56.74
- LGVN 21.23
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.